ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.8802
-0.61%
Brent Oil
83.475
0.42%
Bitcoin
63,474.92
-0.82%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Athersys Inc (ATHX)

  7. Athersys Inc (ATHX) Noticias

ATHX

Athersys (ATHX)

Athersys Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ATHX
FechaHoraFuenteTítuloSímboloCompañía
08/01/202406:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
21/12/202310:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
16/11/202307:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
16/10/202315:52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
10/10/202307:30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
03/10/202315:30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
02/10/202316:04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
25/09/202315:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
21/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
18/09/202320:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
14/09/202309:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
13/09/202316:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
06/09/202313:45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
21/08/202313:36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
17/08/202320:30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
17/08/202315:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
16/08/202316:01Business WireAthersys Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
11/08/202307:00Business WireAthersys Appoints Neema Mayhugh, PhD to its Board of DirectorsNASDAQ:ATHXAthersys Inc
07/08/202316:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ATHXAthersys Inc
31/07/202312:38Business WireAthersys to Host Business Update Conference Call on August 9thNASDAQ:ATHXAthersys Inc
14/07/202315:31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATHXAthersys Inc
14/07/202315:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ATHXAthersys Inc
28/06/202305:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATHXAthersys Inc
08/06/202309:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ATHXAthersys Inc
08/06/202305:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ATHXAthersys Inc
01/06/202315:40Business WirePatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic TraumaNASDAQ:ATHXAthersys Inc
26/05/202316:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ATHXAthersys Inc
23/05/202307:30Business WireAthersys Restructures Debt with SupplierNASDAQ:ATHXAthersys Inc
18/05/202308:58Business WireAthersys Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
15/05/202315:54Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX

Su Consulta Reciente

CCOM
US500
US 500
CCOM
OILBRENT
Brent Oil
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados